Augustine Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Augustine Asset Management's PFE Position: Q2 2025 in Review
Augustine Asset Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 17,720 shares — an estimated $449K sold.
Augustine Asset Management first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $5.9M in Q3 2013. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Augustine Asset Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Augustine Asset Management sold 17,720 Pfizer shares in Q2 2025, an estimated $449K.
- Augustine Asset Management first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
- Augustine Asset Management's Pfizer position peaked at $5.9M in Q3 2013.
- 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Augustine Asset Management's 13F filing for Q2 2025, filed 16 Jul 2025.